Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate LeMaitre Vascular Inc before investing.

In this article, we go over a few key elements for understanding LeMaitre Vascular Inc’s stock price such as:

• LeMaitre Vascular Inc’s current stock price and volume
• Why LeMaitre Vascular Inc’s stock price changed recently
• Upgrades and downgrades for LMAT from analysts
• LMAT’s stock price momentum as measured by its relative strength

About LeMaitre Vascular Inc (LMAT)

Before we jump into LeMaitre Vascular Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

LeMaitre Vascular, Inc. is a provider of medical devices and human tissue cryopreservation services, which are used in the treatment of peripheral vascular disease, end-stage renal disease and cardiovascular disease. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The Company?s product offerings are sold globally, primarily in the United States, Europe, Canada and Asia Pacific. Its products and services include Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts Radiopaque Tape, and Valvulotomes. Its PeriVu Disposable Angioscope is a fiberoptic catheter used for viewing the lumen of a blood vessel.

Want to learn more about LeMaitre Vascular Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about LeMaitre Vascular Inc.

LeMaitre Vascular Inc’s Stock Price as of Market Close

As of September 26, 2023, 4:00 PM, CST, LeMaitre Vascular Inc’s stock price was $53.45.

LeMaitre Vascular Inc is down 4.18% from its previous closing price of $55.78.

During the last market session, LeMaitre Vascular Inc’s stock traded between $55.07 and $56.75. Currently, there are 22.21 million shares of LeMaitre Vascular Inc stock available for purchase.

LeMaitre Vascular Inc’s price-earnings (P/E) ratio is currently at 49.3, which is high compared to the Advanced Medical Equipment & Technology industry median of 29.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

LeMaitre Vascular Inc Stock Price History

LeMaitre Vascular Inc’s (LMAT) price is currently down 7.54% so far this month.

During the month of September, LeMaitre Vascular Inc’s stock price has reached a high of $58.63 and a low of $53.33.

Over the last year, LeMaitre Vascular Inc has hit prices as high as $68.67 and as low as $41.78. Year to date, LeMaitre Vascular Inc’s stock is up 6.41%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused LeMaitre Vascular Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of September 25, 2023,, no analysts have changed their rating of LeMaitre Vascular Inc’s stock over the last month.

Additionally, you'll want to evaluate LeMaitre Vascular Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on LeMaitre Vascular Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

LeMaitre Vascular Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about LeMaitre Vascular Inc (LMAT) by visiting AAII Stock Evaluator.

Relative Price Strength of LeMaitre Vascular Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 25, 2023, LeMaitre Vascular Inc has a weighted four-quarter relative price strength of -3.09%, which translates to a Momentum Score of 53 and is considered to be Average.

Want to learn more about how LeMaitre Vascular Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

LeMaitre Vascular Inc Stock Price: Bottom Line

As of September 26, 2023, LeMaitre Vascular Inc’s stock price is $53.45, which is down 4.18% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like LeMaitre Vascular Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.